novo 1.5 Pill - white round
Generic Name: semaglutide
Pill with imprint novo 1.5 is White, Round and has been identified as Rybelsus (formulation R2) 1.5 mg. It is supplied by Novo Nordisk.
Rybelsus is used in the treatment of Type 2 Diabetes and belongs to the drug class GLP-1 Agonists (Incretin Mimetics). Rybelsus 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for novo 1.5

Rybelsus (formulation R2)
- Generic Name
- semaglutide
- Imprint
- novo 1.5
- Strength
- 1.5 mg
- Color
- White (white to light yellow)
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- GLP-1 Agonists (Incretin Mimetics)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-4815
See also:
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Mounjaro
Mounjaro is used to treat type 2 diabetes in adults. It is a subcutaneous injection that can be ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Basaglar
Basaglar (insulin glargine) is a long-acting insulin that is used to improve blood sugar control in ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Novolog
NovoLog is a fast-acting insulin used to treat diabetes to control blood sugar levels in adults and ...
Soliqua
Soliqua 100/33 (insulin glargine and lixisenatide) is used to treat type 2 diabetes. Includes ...
Toujeo SoloStar
Toujeo (insulin glargine) is an injection used to treat type 1 or type 2 diabetes. Includes Toujeo ...
More about Rybelsus (semaglutide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (292)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.